BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Diabetes mellitus
,
Retina
,
Nosology
,
Rapamycin
,
rs2476601
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Oncostatin M
Summary
General Info
Curated Studies
Most Correlated Studies
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Skin keratinocyte HaCaT cells treated with Ino-C2-PAF and inflammatory cytokines
Lung fibroblast IMR-90 cells treated with oncostatin M
Articular chondrocytes stimulated with IL1 and oncostatin M over various time points
Explore Curated Studies Results
Literature
Most Relevant Literature
Oncostatin M regulates macrophages polarization in osseointegration via yes-associated protein.
Oncostatin M Plays a Critical Role in Survival after Acute Intestinal Ischemia: Reperfusion Injury.
Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenc…
Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice.
Phenotypic variability, not noise, accounts for most of the cell-to-cell heterogeneity in IFN-γ and …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Measurement of Oncostatin M, Leukemia Inhibitory Factor and Interleukin-11 Levels of Patients With P…
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participa…
A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subject…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ